Today: 19 May 2026
Reckitt Benckiser share price slips in early London trade as special dividend reset stays in focus
6 February 2026
1 min read

Reckitt Benckiser share price slips in early London trade as special dividend reset stays in focus

London, Feb 6, 2026, 09:17 GMT — Regular session

  • Reckitt Benckiser shares fell about 0.7% in early trade, tracking a softer UK market.
  • The stock is still adjusting after a 235p special dividend and a 24-for-25 share consolidation that took effect this week.
  • Investors are looking to the company’s Feb. 19 CAGNY presentation for fresh clues on the post-divestment plan.

Shares in Reckitt Benckiser Group plc fell 0.7% to 6,368 pence in early London trading on Friday, after closing at 6,414 pence in the prior session. The stock has traded between 4,585.8 pence and 6,434 pence over the past year.

The move matters because the stock is still settling after a large, one-off return of capital that can distort day-to-day moves and confuse comparisons. On Jan. 7, the company set out plans for a 235 pence-per-share special dividend — about £1.6 billion in total — alongside a 24-for-25 share consolidation, meaning holders received fewer shares with a higher price per share to keep overall value broadly similar.

Reckitt said the share consolidation became effective on Feb. 2 and updated its share capital and voting rights for UK disclosure rules. The company reported 674,005,752 ordinary shares in issue, with 29,252,346 held in treasury, leaving total voting rights of 644,753,406.

The stock had risen in the prior two sessions before Friday’s dip. Reckitt gained 2.23% on Feb. 5 and 2.40% on Feb. 4, based on historical pricing data, as investors repositioned after the corporate action.

Cash returns have also run alongside buybacks. Reckitt confirmed on Feb. 2 it had completed the second tranche of its £1 billion share buyback programme, purchasing 3,461,470 shares at an average price of £59.46 between Oct. 22 and Jan. 28, and holding those shares in treasury.

The broader tone in London was not helping. The FTSE 100 was down about 0.3% in early trade.

Reckitt has framed the capital return as part of a broader reshaping after selling its Essential Home business. In a Dec. 31 statement on completing that divestment to Advent International, Chief Executive Kris Licht called it “a major step forward in our strategy.” reckitt.com

Investors now want detail on what the new Reckitt looks like, not just how much cash it sends back. The company said Licht and Chief Financial Officer Shannon Eisenhardt will present at the Consumer Analyst Group of New York conference on Feb. 19, with a webcast scheduled for 15:00-15:45 GMT.

The next near-term mechanical catalyst is the dividend itself. Data published by Hargreaves Lansdown shows the special dividend is due to be paid on Feb. 20, after the stock went ex-dividend on Feb. 2 — meaning new buyers after that date are not entitled to the payout.

But the trade can still go wrong for holders who treat the dividend as “free money.” A special dividend is a cash-out, not a fix for pricing pressure, slower volumes or a tough consumer backdrop, and the stock can stay choppy as funds rebalance around the corporate action and sector flows.

Stock Market Today

  • India IPO Fundraising Drops to Two-Year Low in Early 2026 with Uncertain Outlook for H2
    May 19, 2026, 6:19 AM EDT. India's IPO fundraising has plunged to Rs 56,322 crore in the first five months of 2026, marking a sharp decline from Rs 82,678 crore in the same period last year and a two-year low, according to Primedatabase. Contributing factors include market volatility, geopolitical tensions, and cautious investor behavior amid global uncertainties. Notably, average subscription rates fell to roughly 2x in early 2026 from 38x in H2 2025, signaling weakened appetite. Despite a healthy pipeline with major listings from NSE and Jio Platforms expected in the second half, experts warn recovery will be cautious and selective. Institutional investors now favor profitable, scalable firms over aggressive growth models. The primary market slowdown contrasts with record 2025 fundraising and raises concerns about H2 momentum.

Latest articles

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

19 May 2026
Hesai Group shares rose 2.68% to $22.60 in U.S. premarket trading after reporting a first-quarter profit and confirming it will supply lidar sensors for Mercedes-Benz Level 3 autonomous models. The company shipped 471,723 lidar units, up 140.9% year-on-year, and posted revenue of RMB680.6 million ($98.7 million). Net income reached RMB18.3 million, reversing a loss from a year earlier.
Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Compass Group share price slips again as AI fears linger after Q1 update
Previous Story

Compass Group share price slips again as AI fears linger after Q1 update

Molina Healthcare stock sinks premarket after 2026 outlook miss, Medicare exit plan
Next Story

Molina Healthcare stock sinks premarket after 2026 outlook miss, Medicare exit plan

Go toTop